Scienjoy (NASDAQ:SJ) vs. Mercurity Fintech (NASDAQ:MFH) Head-To-Head Comparison
Should You Buy or Sell Repligen Stock? Get The Latest RGEN Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Stay updated with breaking news from Repligen Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Should You Buy or Sell Repligen Stock? Get The Latest RGEN Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Repligen (NASDAQ:RGEN – Get Rating) updated its FY23 earnings guidance on Tuesday. The company provided EPS guidance of $2.35-$2.42 for the period, compared to the consensus EPS estimate of $2.64. The company issued revenue guidance of $720-$760 million, compared to the consensus revenue estimate of $779.97 million. Wall Street Analyst Weigh In A number of […]
Geneva Capital Management LLC reduced its position in Repligen Co. (NASDAQ:RGEN – Get Rating) by 8.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 129,065 shares of the biotechnology company’s stock after selling 12,348 shares during the quarter. Geneva […]
Repligen (NASDAQ:RGEN – Get Rating) is scheduled to be releasing its earnings data before the market opens on Tuesday, May 2nd. Analysts expect Repligen to post earnings of $0.59 per share for the quarter. Repligen has set its FY23 guidance at $2.61-2.69 EPS and its FY 2023 guidance at $2.61-$2.69 EPS.Persons that are interested in […]
Repligen Co. (NASDAQ:RGEN – Get Rating) – Stock analysts at William Blair lifted their Q1 2023 earnings per share estimates for Repligen in a research note issued to investors on Wednesday, April 12th. William Blair analyst M. Larew now expects that the biotechnology company will earn $0.72 per share for the quarter, up from their […]